Why is Tatva Chintan falling/rising?

As of 04-Jul, Tatva Chintan Pharma Chem Ltd is currently priced at Rs 999.00, reflecting a decrease of Rs 21.0 or 2.06%. The stock has underperformed its sector by 1.9% today and has experienced a trend reversal, falling after two consecutive days of gains. Despite touching an intraday high of Rs 1055, it also reached a low of Rs 999. The stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally positive trend. Additionally, the stock has shown a significant increase in investor participation, with delivery volume rising by 366.33% against the 5-day average. However, it has a negative one-year return of -13.92%, contrasting with the Sensex's positive return of 4.23%.
In the broader market context, Tatva Chintan's short-term performance over the past week shows a gain of 6.28%, significantly outperforming the Sensex, which has declined by 0.74%. This suggests that while the stock is facing a short-term decline, its recent performance has been relatively strong compared to the market. The company maintains a low average debt-to-equity ratio, which is a positive factor that may support its stability and investor confidence in the long run. However, the recent price drop indicates that market sentiment may be cautious, possibly due to the stock's overall negative performance over the past year and the recent trend reversal.